Continuing your IDMP Journey with
Bristol Myers Squibb and GSK

How have the EMA’s latest updates affected your IDMP preparation efforts? Watch this fireside chat with Patrick Middag, Bristol Myers Squibb, and Alastair Nixon, GSK to hear how they are adapting to the new IDMP guidance and using it as an opportunity to derive even greater value from their RIM solution.

They also reviewed several steps that your organization can take in the coming months to prepare for compliance.